New drugs and new indications drive specialty

Specialty treatments continue to grow as a portion of pharmacy spend. They now account for more than half of pharmacy spend — 52 percent in 2020 — and are concentrated in relatively few therapeutic categories. Specialty trend has continued to remain high over recent years, but that spend is now largely driven by members new to treatment. Utilization is now the main driver of specialty drug trend as we have successfully implemented approaches to mitigate manufacturer driven price inflation.

A graphic with two parts. Part one: 98 percent of utilization increase is from conditions with new therapies and indications. Part two: 5 therapeutic categories drive 90 percent of spend.